When AI designs a drug, who gets the credit?
محرر واقع مصر
إم آي تي تكنولوجي ريفيو
21 أغسطس, 2026
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
